Keywords
Sarcoma
Socket
Masquerade syndrome
Immunohistochemistry
Categories
How to Cite
Abstract
Background: Diabetic Retinopathy (DR) is one of the most common complications of Diabetes Mellitus (DM),
and it is a leading cause of vision loss in the working-age population globally.
Objective: This study aimed to determine the prevalence of DR at a population level, the clinical profile, and the
factors associated with DR in Southwestern Uganda.
Methods: This was a secondary analysis of data generated by a large-scale four-year community screening
program through the “Lions Diabetic Retinopathy Screening and Treatment Project for Southwestern Uganda.”
Patients with known DM underwent DR screening, and fundus photography was performed on all patients. An
ophthalmologist subsequently graded these photographs. Patients with gradable fundus images were included
for analysis.
Results: Of the 1,515 diabetic patients who were screened, 1,120 were considered for analysis. The majority were
female and had a family history of DM. The overall prevalence of DR was 15.1% (95% CI, 11.9 - 18.9), of which
63% had referable DR and 20.2% had sight-threatening DR. Factors associated with any DR were: duration of DM
(AOR 2.1 [95% CI 1.3- 3.5]), poor glycemic control (AOR 1.9 [95% CI 1.2 - 3.0]), and hypertension (AOR 2.0 [95% CI
1.3-3.4]).
Conclusion: This study has provided the baseline prevalence of DR in Southwestern Uganda and the proportion
of sight-threatening DR that can be used for planning service delivery in the region.
References
Blindness GBD, Vision Impairment C, Vision Loss
Expert Group of the Global Burden of Disease Study.
Causes of blindness and vision impairment in 2020
and trends over 30 years, and prevalence of avoidable
blindness in relation to VISION 2020: the Right to
Sight: an analysis for the Global Burden of Disease
Study. Lancet Glob Health. 2021; 9(2):e144-e60.
Ding J, Wong TY. Current epidemiology of diabetic
retinopathy and diabetic macular edema. Current
Diabetes Reports. 2012; 12(4):346-354.
Ophtalmology AAo. Basic and Clinical Science
Course 12: Retinal and Vitreous. Amer Academy
Ophthalmol. 2017: 83: 6.
Tarr JM, Chopra M, Kohner EM, Chibber R.
Pathophysiology of diabetic retinopathy. Intern
Scholarly Res Notices. 2013; 2013:13.
Ophthalmology ICO. Updated ICO Guidelines for
Diabetic Eye Care. Intern Council Ophtalmol. 2017:
-40.
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung
N, et al. Global prevalence of diabetic retinopathy
and projection of burden through 2045: systematic
review and meta-analysis. Ophthalmology. 2021;
(11):1580-91.
Burgess PI, MacCormick IJ, Harding SP, Bastawrous
A, Beare NA, Garner P. Epidemiology of diabetic
retinopathy and maculopathy in Africa: a systematic
review. Diabetic Med. 2013; 30(4):399-412.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga
S, Unwin N, et al. Global and regional diabetes
prevalence estimates for 2019 and projections for
and 2045: Results from the International
Diabetes Federation Diabetes Atlas, 9(th) edition.
Diabetes Res Clin Practice. 2019; 157:107843.
Bahendeka S, Wesonga R, Mutungi G, Muwonge J,
Neema S, Guwatudde D. Prevalence and correlates
of diabetes mellitus in Uganda: a populationbased
national survey. Trop Med Intern Hlth. 2016;
(3):405-416.
Seba EG, Arunga S, Bwonya BD, Twinamasiko A.
Prevalence, risk factors and causes of visual impairment
in patients with diabetes at Mbarara Regional Referral
Hospital, South Western Uganda; A hospital-based
study. J Ophthalmol Eastern, Central Southern Africa.
; 15(01):9-13.
Natarajan S, Jain A, Krishnan R, Rogye A,
Sivaprasad S. Diagnostic accuracy of communitybased
diabetic retinopathy screening with an offline
artificial intelligence system on a smartphone. JAMA
Ophthalmol. 2019; 137(10):1182-88.
Arunga S, Tran T, Tusingwire P, Kwaga T, Kanji
R, Kageni R, et al. Diabetic retinopathy screening
program in Southwestern Uganda: DR Uganda.
JOECSA. 2021; 24(2):20-26.
WHO. Blindness and visual impairment: World
Health Organization; 2020 [updated October 2020
/10/2020]
Norman J. Managing diabetes with blood glucose
control: Endocrineweb; 2021.
UBOS. Population Projections By District, 2015 to
In: UBOS, editor. Kampala, Uganda 2020.
Cleland CR, Burton MJ, Hall C, Hall A, Courtright P,
Makupa WU, et al. Diabetic retinopathy in Tanzania:
prevalence and risk factors at entry into a regional
screening programme. Trop Med Intern Hlth. 2016;
(3):417-426.
Lewis AD, Hogg RE, Chandran M, Musonda L,
North L, Chakravarthy U, et al. Prevalence of diabetic
retinopathy and visual impairment in patients with diabetes mellitus in Zambia through implementing a
mobile diabetic retinopathy screening project in the
Copperbelt province: a cross-sectional study. Eye.
(London, England). 2018; 32(7):1201-8.
Magliah SF, Bardisi W, Al Attah M, Khorsheed
MM. The prevalence and risk factors of diabetic
retinopathy in selected primary care centers during
the 3-year screening intervals. J Family Med Primary
Care. 2018; 7(5):975-981.
Cardoso CRL, Leite NC, Dib E, Salles GF. Predictors
of development and progression of retinopathy in
patients with Type 2 diabetes: Importance of blood
pressure parameters. Scientific Reports. 2017;
(1):4867.